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CASE PRESENTATION
The male child was born to healthy, non-related Caucasian
parents. Two older brothers were healthy. Pregnancy and
delivery were uneventful. At the age of 4 weeks, he was
admitted to the hospital for failure to thrive and renal
failure (creatinine 3.7 mg/dl: urea nitrogen 150 mg/dl: base
excess 10 mmol/l). Proteinuria (300 mg/day) was
moderate and hematuria was absent. Ultrasound revealed
small hyperechogenic (o3rd percentile) kidneys. During
early childhood, renal ultrasound also demonstrated
cortical cyst formation.
A voiding cystogram was normal and reflux was
excluded. Anemia (hematocrit 28%) and arterial
hypertension (relative risk 143/98 mm Hg) were
encountered. Starting at the age of 1 year, renal function
parameters (creatinine and urea nitrogen) showed slow
but permanent progression over the following years.
Height and weight dropped below the 3rd percentile
for age and gender. Hernia repair was performed on
the right side with a take down of the testes on the
same side, which had to be repeated 4 years later.
At the age of 9 years, creatinine was 4.3 mg/dl
(glomerular filtration rate 15 ml/min). Therapy with
recombinant human growth hormone was started at the
age of 8 years, resulting in catch-up growth to the 3rd
percentile for age.
Hemodialysis was started at the age of 10 years. At
the age of 10.5 years, the child received a deceased
donor-related kidney graft and growth hormone
therapy was stopped. However, after transplantation
the child did not continue catch-up growth, but
instead, growth arrest was encountered. Already
before transplantation, the child showed constant
weight gain with increasing appetite, despite continuous
tapering of the corticosteroid dosage, and body
weight reached the 90th percentile. At the last visit
(age of 14 years), he displayed hypergonadotropic
hypogonadism, and no signs of puberty were present
(Figure 1a).
Liver enzymes were found elevated and a liver biopsy
showed discrete steatosis hepatis without any specific
pathological finding. Dyslipidemia was diagnosed (serum
cholesterol 290 mg/dl, triglycerides 480 mg/dl, Lp(a)
88.8 mg/dl). An intravenous glucose tolerance test was
normal, glycosylated hemoglobin was 5.7 %, and
fasting glucose levels were normal. A reduction of all
immunoglobulin (Ig) isotypes was also observed
(IgG, IgA, IgM).
From birth on, muscular weakness was present.
Mental and motor development was retarded. At 4 years
of age, the child was able to walk, but continued to
speak only few words and showed behavioral
abnormalities resembling autism. In contrast to the
poor growth, the head circumference was 497th
percentile. Eye examination and magnetic resonance
imaging of the head remained without pathological
findings.
At the age of 10 years, magnetic resonance imaging
was performed, demonstrating small hyperechogenic
kidneys with multiple small cortical cysts (Figure 1b).
Magnetic resonance imaging of the liver and the pancreas
were normal, and no signs of cholangiodysplasia or
hepatic cysts were present.
In order to verify the presence of disease-causing
chromosomal rearrangements, the patient was tested by
conventional cytogenetics, array-based comparative
genomic hybridization (CGH) and fluorescence in situ
hybridization (FISH). Karyotyping of GTG-banded
chromosomes from peripheral blood lymphocytes at 450
bands resolution was performed according to standard
procedures and did not reveal any chromosomal
abnormality (46, XY). Array CGH was carried out using a
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sub-megabase resolution tiling path bacterial artificial
chromosome (BAC) array, consisting of the human 32k
Re-Array set (DNA kindly provided by Pieter de Jong,
http://bacpac.chori.org/pHumanMinSet.htm),1–3 the 1 Mb
Sanger Clone set (clones kindly provided by Nigel Carter,
Wellcome Trust Sanger Centre, Hinxton, UK)4 and 390
sub-telomeric clones (assembled by members of the COST
B19 initiative: molecular cytogenetics of solid tumors).
Detailed protocols are available at the following website
(http://www.molgen.mpg.de/~abt_rop/molecular_
cytogenetics/ProtocolsEntry.html). Three times 300 ng of
patient’s DNA and pooled control DNA were labelled with
Cy5 and Cy3, respectively, using the Bioprime CGH
labelling kit (Invitrogen, Carlsbad, CA, USA). Images were
scanned by means of an Axon 4100A and analyzed by
GenePix Pro 6.0 software (Axon Instruments, Foster City,
CA, USA). Further analysis and visualization of array CGH
data was carried out using the software package
CGHPRO.5 No background subtraction was performed.
Raw data were normalized by ‘Subgrid LOWESS’. Copy
number gains and losses were determined by a
conservative log 2 ratio threshold of 0.3 and 0.3,
respectively. Profile deviations consisting of three or
more neighboring BAC clones were considered as
genomic aberrations and evaluated by FISH, unless they
coincided with a published polymorphism as listed in the
Database of Genomic Variants, (http://projects.tcag.ca/
variation/; version 13 December 2005). For visualizing the
content of low-copy repeats in the ratio plots (Figure 2),
each BAC clone was classified into one out of seven
categories and color-coded as described previously.5
Array CGH detected a 1.4 Mb interstitial deletion on
chromosome 17q12 (Figure 2). This deletion was
indicated by 16 clones, which were flanked by
M2196A18 (proximal breakpoint spanning clone;
31.81–32.07 Mb from pter) and M2344A06 (distal
breakpoint spanning clone 33.26–33.38 Mb from pter).
Both breakpoints coincided with published DNA copy
number polymorphisms (proximal;6 distal7) and were
found to be enriched for low-copy repeats, which,
according to Segmental Duplication Database
(http://humanparalogy.gs.washington.edu/), share a
56 kb segment with 99.3 % sequence similarity. The
list of genes within the deleted region (Table 1) is
based on version November 2005, v35 of the Ensembl
genome browser.
For verification of array CGH results by FISH, BAC
clones RP11-445F12 and RP11-115K3, mapping to
chromosome 17q12, were obtained from the RZPD
(Deutsches Resourcenzentrum fu¨r Genomforschung,
Berlin, Germany) and were labelled with spectrum
orange using nick translation. Cep17 (Vysis, Downers
Grove, IL, USA), a spectrum green labelled probe
targeting the centromere of chromosome 17, was
used as control probe. Hybridizations were performed
on metaphase spreads prepared from peripheral
blood lymphocytes. Chromosomes were
counterstained with 4,6-diamidino-2-phenylindole.
As shown in Figure 3, these experiments
confirmed the deletion in the patient and showed
normal two signals in both parents in all metaphases
analyzed.
RENAL DIAGNOSIS
Cystic renal disease owing to a de novo 1. 4 Mb heterozygous
deletion of 17q12 including the entire TCF2/HNF-1b gene
locus.
a b
Figure 1 | Phenotype of the patient at the age of 13 years. (a) Truncal obesity, short neck, and large ears, and (b) magnetic resonance
imaging of the abdomen using gadolinium as the contrast medium. Note the small, hyperechogenic kidneys containing multiple cortical small
cysts (arrows).
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Figure 2 | Array CGH profile of chromosome 17. Cy3/Cy5 intensity ratios of each clone are plotted in a size-dependent manner along
the chromosome ideograms. The red and green lines indicate the log 2 ratio thresholds 0.3 (loss) and 0.3 (gain), respectively. For
visualizing the content of low-copy repeats in the ratio plots, each BAC clone was classified into one out of seven categories and color-coded
as described previously.7 The color code is given by the color bar to the right (e.g., red¼ no low-copy repeats). Both, the accumulation
of low-copy repeats and the presence of DNA copy number polymorphisms at the breakpoints, as shown by the level bars in the close-up,
suggest that these sites are hot spots for chromosomal rearrangements.
Table 1 | Known genes located within the deleted region on chromosome 17q12
Gene ID Name Position (Mb)
PIGW Phosphatidylinositol glycan, class W 31.96
ZNF403 Zinc-finger protein 403 31.97
NP_077284.1 Short-chain dehydrogenase/reductase 32.02
NP_079140.2 tRNA/rRNA methyltransferase 32.03
LHX1 LIM homeobox protein 1 32.36
AATF Apoptosis antagonizing transcription factor 32.38
ACACA Acetyl-CoA carboxylase 1 32.51
Q96TB3_HUMAN Envelope protein (Fragment) 32.76
NP_775896.3 No annotation 32.8
TADA2L Transcriptional adapter 2-like 32.84
DUSP14 Dual specificity protein phosphatase 14 (MAP kinase phosphatase 6) 32.92
AP1GBP1 AP1 gamma subunit binding protein 1 32.95
DDX52 Dead box protein 52 33.04
TCF2 (HNF1b) Hepatocyte nuclear factor 1-beta 33.12
MAP kinase, mitogen-activated protein kinase.
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DISCUSSION
Congenital abnormalities of the kidney and the urogenital
tract are among the most common disorders in childhood.
Heterogeneous phenotypes, often complicated by a variety of
additional clinical symptoms, have hindered the identifica-
tion of candidate genes and their correlation to specific
clinical features. Recently, it has been speculated that about
15 % of human genetic disorders are caused by sub-
microscopic genomic imbalances,8 not detectable at the
average resolution of 10 Mb as provided by conventional
cytogenetics. Identification of such small aberrations would
narrow down the chromosomal regions of interest and
considerably reduce the number of candidate genes. Depend-
ing on the chromosomal region, genomic imbalances of this
size may encompass 100 or more candidate genes. By means
of array CGH, we have identified a 1.4 Mb deletion on
chromosome region 17q12 in a patient suffering from
unclassified kidney disease and multiple clinical and
biochemical abnormalities. The heterozygous deleted region
comprises 12 known genes and some of them have already
been linked to clinical features that are present in our patient.
One gene out of this list is transcription factor 2/hepatocyte
nuclear factor-1b (TCF2/HNF-1b), which plays a role in
tissue-specific gene expression, most prominently in the liver,
kidney, and pancreas. Haploinsufficiency of TCF2/HNF-1b,
either owing to mutations or deletions, has already been
implicated in pancreatic atrophy with maturity onset of
diabetes in the young (MODY5), abnormal levels of liver
enzymes, urogenital abnormalities, including atresia of the
vas deferens and azoospermia in the affected males, and,
most important, a wide range of renal manifestations.9–11
In contrast to autosomal-dominant or autosomal-reces-
sive polycystic kidney disease, kidneys of patients carrying
TCF2/HNF-1b mutations are usually not enlarged. In some
cases, they have been described as ‘hypoplastic’ and, on
ultrasound, they often appear hyperechogenic, and cortico-
medullary differentiation is poor, as it is the case in our
patient. The cysts are located in the cortex, are multiple, and
have a diameter less then 10 mm (microcysts). Histologically
glomerular enlargement with and without glomerular cysts is
present. The proximal tubular system is dilated. Upon
electronmicroscopy, a slight thickening of the basal mem-
brane can be encountered. Also cases of oligomeganephronia
have been reported. The mesangium is typically without any
pathological findings.
Interestingly, a rapid progression to end-stage renal
disease in childhood, as seen in our patient, is unusual in
carriers of TCF2/HNF-1b abnormalities.9,12,13 Therefore, we
speculate that the deletion of additional genes located in the
1.4 Mb region aggravated the renal phenotype. One such gene
in the deleted interval is LHX1 (LIM homeobox 1; Table 1),
which, together with TCF2/HNF-1b and PAX8, represents
one of the earliest regulators in the pronephric anlage. TCF2/
HNF-1b inhibits kidney formation and LIM1 acts nephro-
genic.14–16 However, as shown in Xenopus, this relationship is
not purely antagonistic, because TCF2/HNF-1b can only
rescue PAX8/LIM1-induced enlargement and ectopic tubule
formation and cannot suppress thickening of tubules and
cyst-like structures.17 The deletion revealed here most likely
emerged through non-allelic homologous recombination of
the two breakpoint flanking low-copy repeats, a process
typical for genomic disorders. Usually, chromosomal break-
points in genomic disorders are recurrent. Therefore, the 14
patients previously reported by Ulinski et al.,9 with renal
manifestations and deletions of TCF2/HNF-1b, which are
overlapping with our aberration, may share the same
a
b
Figure 3 | Confirmation of array CGH results by FISH. FISH with
BAC probes (a) RP11-445F12 and (b) RP11-115K3 mapped to 17q12
labelled with spectrum orange and control probe cep17 labelled with
spectrum green confirm the heterozygous deletion in the patient.
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chromosomal rearrangement; thus, these cases, as well as our
patient, may establish a novel micro-deletion syndrome.
Genetic analysis will not only improve classification of
renal disorders with complex phenotype, but genotype–phe-
notype comparisons between patients with the same genetic
defect will also have therapeutic implications. Our patient
does not suffer from diabetes yet, but, based on array CGH
data, he is at high risk of developing diabetes in the course of
disease progression, thus close monitoring of his glucose
metabolism should be considered. These findings also point
to the fact that the absence of a family history of renal cystic
disease and diabetes does not preclude the presence of de
novo mutations or deletions and that such patients should
always be investigated for underlying genetic causes.
We conclude that array CGH is a powerful technique,
which will assist in the classification of renal disorders and
will have impact on therapy.
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